Former AIB chief financial officer Mark Bourke, a key member of the team behind the bank’s initial public offering (IPO) ...

The lender was getting ready to list in Lisbon next month despite the unsteadiness in global markets and could be valued up ...

Portugal's fourth-largest lender Novo Banco plans to go ahead with an initial public offering (IPO) possibly in June or September despite market volatility caused by global trade tensions, Chief ...

Portugal's fourth-largest lender Novo Banco, which is preparing for an initial public offering (IPO), said on Tuesday its ...

Novo Nordisk scored a huge legal victory that largely restricts compounding pharmacies from marketing or selling cheaper, unapproved versions of the drugmaker's blockbuster weight loss drug Wegovy ...

Novo Nordisk (NYSE: NVO), the Danish drugmaker that's been riding high ever since it began putting out Ozempic and Wegovy GLP-1 injectables for treatment of diabetes and weight loss, got another ...

Novo Nordisk launched the anti-obesity drug Wegovy in the United States in 2021. File photo: Mads Claus Rasmussen/Ritzau Scanpix Shares in Danish drugmaker Novo Nordisk, maker of the blockbuster ...

Portugal has opted for a two-stage auction model for its inaugural offshore wind tender and has set itself time limits for launching the competitive process within six months. Portugal is seen as a ...

This May, Portugal becomes the meeting point for two powerful movements — the Conscious Health Summit and The FiVth Empire — aligning to offer a one-of-a-kind transformational weekend. A three-day ...

Novo Nordisk (NYSE:NVO) has filed for U.S. approval of an oral version of its blockbuster weight loss drug Wegovy, the company confirmed to BioPharma Dive. The Danish drugmaker disclosed the ...

Circumstances changed about two years ago, and I decided to move to Portugal with my two kids. We've lived here for about a month, and everything is different. Life is so much better. I made the ...

April 14 (Reuters) - Danish drugmaker Novo Nordisk NOVOb.CO said on Monday several hundred counterfeit units of its diabetes drug Ozempic were being distributed outside its authorized supply chain ...